Skip to main content
TipRanks
Go Ultimate75% OFF

Scandinavian Real Heart AB (HEART) Stock Price & Analysis

2 Followers

HEART Stock Chart & Stats

kr 15.20-kr 0.40(-2.56%)
At close: 5:30 PM GMT+1
kr 15kr 17.5Aug 24Sep 7Sep 21Oct 5Oct 19Nov 2Nov 16
Day’s Range
SEK 14.70 - SEK 15.90
52-Week Range
SEK 12.90 - SEK 23.70
Previous Close
SEK 15.60
Volume
N/A
Average Volume (3M)
2,587
Market Cap
SEK 129.17M
Enterprise Value
SEK 151.30M
Total Cash (Recent Filing)
SEK 27.94M
Total Debt (Recent Filing)
SEK 5.40M
Price to Earnings (P/E)
―
Beta
0.15
Next Earnings
Feb 25, 2027 (Est.)
EPS Estimate
N/A
Next Dividend Ex-Date
N/A
Dividend Yield
N/A

Bulls Say, Bears Say

Bulls Say

Modest Leverage

The company’s modest debt burden provides greater financial flexibility than a highly leveraged medtech developer. Low leverage can reduce interest pressure and preserve options to fund research, regulatory work, and commercialization while the product remains pre-commercial.

Focused Artificial Heart Platform

A focused platform targeting severe heart failure addresses a significant clinical need and gives the company a clear long-term strategic identity. If development and validation succeed, the product could support a specialized position in advanced mechanical circulatory support.

Structured Development Path

The company is pursuing the key development stages required for a regulated implantable medical device, rather than relying only on an early concept. Progress across validation, regulatory preparation, and commercialization planning can build a foundation for future market access.

Bears Say

Pre-Revenue Business Model

The absence of a meaningful and repeatable revenue base means the company has not yet demonstrated commercial adoption or operating scale. Future funding and value creation therefore remain dependent on successfully converting development work into approved, sellable products.

Persistent Cash Burn

Sustained negative operating and free cash flow shows that the business cannot currently fund its activities internally. Continued research, validation, and regulatory work will likely require further financing, increasing execution dependence and pressure on future capital allocation.

Declining Equity Base

A shrinking equity base alongside continuing losses indicates that accumulated value is being consumed before commercial scale is reached. If this pattern persists, additional financing could become increasingly important and may create further dilution risk for existing shareholders.

HEART FAQ

What was Scandinavian Real Heart AB’s price range in the past 12 months?
Scandinavian Real Heart AB lowest stock price was kr 12.90 and its highest was kr 23.70 in the past 12 months.
What is Scandinavian Real Heart AB’s market cap?
Scandinavian Real Heart AB’s market cap is kr 129.17M.
When is Scandinavian Real Heart AB’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Scandinavian Real Heart AB’s earnings last quarter?
Scandinavian Real Heart AB released its earnings results on Aug 26, 2026. The company reported -kr 2.82 earnings per share for the quarter.
Is Scandinavian Real Heart AB overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Scandinavian Real Heart AB pay dividends?
Scandinavian Real Heart AB does not currently pay dividends.
What is Scandinavian Real Heart AB’s EPS estimate?
Scandinavian Real Heart AB’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Scandinavian Real Heart AB have?
Scandinavian Real Heart AB has 8,497,797 shares outstanding.
What happened to Scandinavian Real Heart AB’s price movement after its last earnings report?
Scandinavian Real Heart AB reported an EPS of -kr 2.82 in its last earnings report. Following the earnings report the stock price went down -3.75%.
Which hedge fund is a major shareholder of Scandinavian Real Heart AB?
Currently, no hedge funds are holding shares in SE:HEART
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology